[SCHEDULE 13G/A] Cardinal Health, Inc. SEC Filing

Rhea-AI Filing Summary

Equitable Holdings, Inc. (EQH) filed a Form 144 disclosing a proposed insider sale under Rule 144.

• Seller & broker: Mark Pearson (per past-sale table) intends to sell 30,000 common shares through Morgan Stanley Smith Barney LLC.
• Market value: At the reference price, the shares are valued at $1,602,300.
• Sale timing & venue: Target date 07/15/2025; shares to be sold on the NYSE.
• Outstanding shares: 303,895,221; the proposed sale equals roughly 0.01 % of shares outstanding.
• Prior activity: The same account executed four 10b5-1 sales over the last three months, totaling 60,000 shares for gross proceeds of ≈ $3.18 million.
• Source of shares: 20,000 shares were acquired via option exercise on 07/15/2025; 10,000 via RSUs on 02/14/2022.

No additional financial metrics, earnings data, or business updates were provided; the filing is limited to disclosure of planned insider transactions.

Positive

• Transparent 10b5-1 plan indicates the sale is pre-scheduled, reducing concerns of opportunistic trading.

Negative

• Continued insider selling (90 k shares in 3 months) may signal limited confidence and could pressure near-term sentiment.

Insights

Insider Transactions Analyst

TL;DR: Routine-size insider sale (0.01 % float); modest negative sentiment, immaterial fundamental impact.

The Form 144 reveals a forthcoming 30 k-share sale worth ~$1.6 M, following 60 k shares already sold in the prior quarter. While serial selling can raise eyebrows, the cumulative 90 k shares represent just 0.03 % of EQH’s 303.9 M shares outstanding, limiting dilution or supply risk. Use of a 10b5-1 plan and transparent Rule 144 notice suggest pre-planned diversification rather than reactive selling. Absent any new adverse operational data, I view the filing as neutral to slightly negative: it may pressure sentiment but is unlikely to shift valuation multiples.

Portfolio Manager

TL;DR: Insider cashes out $1.6 M; scale too small to alter portfolio stance.

From an allocation viewpoint, a 30 k-share dump on a >300 M-share base is noise. Liquidity on NYSE should absorb it without affecting spreads. Nonetheless, repeated insider selling can weigh on perception of forward prospects, especially lacking offsetting insider buys. Investors may monitor if additional Form 144s surface. I assign minimal fundamental impact but note a marginal uptick in sentiment risk.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

CARDINAL HEALTH INC

(Name of Issuer)

Common Stock

(Title of Class of Securities)

14149Y108

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 14149Y108

1

Names of Reporting Persons

BlackRock Portfolio Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 10,398,781.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 11,291,592.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

11,291,592.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.7 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: CARDINAL HEALTH INC
(b)	Address of issuer's principal executive offices: 7000 CARDINAL PLACE, DUBLIN, OHIO, 43017
Item 2.
(a)	Name of person filing: BlackRock Portfolio Management LLC In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the "Reporting Business Units") of BlackRock, Inc. and its subsidiaries and affiliates. It does not include securities, if any, beneficially owned by other business units whose beneficial ownership of securities are disaggregated from that of the Reporting Business Units in accordance with such release.
(b)	Address or principal business office or, if none, residence: BlackRock Portfolio Management LLC, 50 Hudson Yards New York, NY 10001
(c)	Citizenship: See Item 4 of Cover Page
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 14149Y108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 11,291,592
(b)	Percent of class: 4.7%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 10,398,781
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 11,291,592
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of CARDINAL HEALTH INC. No one person's interest in the common stock of CARDINAL HEALTH INC is more than five percent of the total outstanding common shares.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit 99
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BlackRock Portfolio Management LLC

Signature:	Spencer Fleming
Name/Title:	Managing Director
Date:	07/15/2025

Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7

FAQ

How many Equitable Holdings (EQH) shares are proposed for sale in the Form 144?

The filing covers 30,000 common shares.

What is the estimated market value of the EQH shares to be sold?

The aggregate market value is $1,602,300.

When is the planned sale date for the EQH Form 144 transaction?

The approximate sale date disclosed is 07/15/2025.

What percentage of EQH’s outstanding shares does this sale represent?

About 0.01 % of the 303,895,221 shares outstanding.

How many shares has the filer sold in the past three months?

Past 10b5-1 sales total 60,000 shares with gross proceeds of roughly $3.18 million.

Which broker will handle the proposed EQH share sale?

Morgan Stanley Smith Barney LLC, Executive Financial Services division.